A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
A quiet few days ahead weather wise
A landlord from Bristol has been fined for dumping rubbish in Salford.
The mother of an autistic boy robbed and stripped in a city centre car park has been ‘overwhelmed’ by messages of support.